| ²é¿´: 455 | »Ø¸´: 2 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÖú·Òë
|
|
|
The preclinical evaluation of combining DLL4 inhibition and cytotoxic agents represents another area of great clinical importance. Blockade of VEGF exhibits clinical potency predominantly when combined with chemo- or radiation therapy. |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
312Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
ÉúÎïÓëÒ½Ò©273Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ר˶0854³õÊÔ¿¼²Ä¿Æ»ù£¬Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
0703»¯Ñ§
ÒѾÓÐ15È˻ظ´
0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö
ÒѾÓÐ9È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ10È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´

fuboluben
Ìú¸Ëľ³æ (СÓÐÃûÆø)
- ·ÒëEPI: 51
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 5949.4
- É¢½ð: 8
- ºì»¨: 2
- Ìû×Ó: 143
- ÔÚÏß: 143.9Сʱ
- ³æºÅ: 1148022
- ×¢²á: 2010-11-16
- רҵ: ΢ÉúÎïÒ©Îï

2Â¥2013-06-15 12:10:48
fuboluben
Ìú¸Ëľ³æ (СÓÐÃûÆø)
- ·ÒëEPI: 51
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 5949.4
- É¢½ð: 8
- ºì»¨: 2
- Ìû×Ó: 143
- ÔÚÏß: 143.9Сʱ
- ³æºÅ: 1148022
- ×¢²á: 2010-11-16
- רҵ: ΢ÉúÎïÒ©Îï

3Â¥2013-06-15 16:08:48














»Ø¸´´ËÂ¥